Ploeg R J
Department of Surgery, University of Leiden, The Netherlands.
Transplantation. 1990 Feb;49(2):281-4. doi: 10.1097/00007890-199002000-00011.
This is a preliminary report of a European Multicenter Trial of the efficacy and safety of the UW solution in kidney preservation. The results obtained with the UW solution are compared with those obtained with Euro-Collins solution in a prospectively randomized study. To date 257 patients have been evaluated, with 128 receiving kidneys preserved in UW solutions and 129 receiving kidneys preserved in Euro-Collins solutions. Demographic characteristics of donors and recipients were identical in both groups. Median (and range) preservation times were similar (24 hr in EC and 24 hr in UW). Maximum preservation time in each group was about 48 hr. The results show that the UW solution is a safe preservation solution for kidneys, with postoperative renal functions, at least, equivalent to those seen in patients transplanted with kidneys preserved in EC solution. In this preliminary analysis of 257 kidneys, use of the UW solution resulted in a more rapid reduction in postoperative serum creatinine, higher creatinine clearance rate, and less postoperative dialysis (21% vs. 31%) when compared with kidneys preserved in EC solution. This study indicates that the UW solution is an effective preservation medium for clinical kidney transplantation. It supports the use of UW solution as a general flushout and cold storage solution for all intraabdominal organs used for transplantation.
这是关于UW液在肾脏保存中有效性和安全性的欧洲多中心试验的初步报告。在一项前瞻性随机研究中,将UW液的研究结果与欧洲柯林斯液的结果进行了比较。迄今为止,已评估了257例患者,其中128例接受了用UW液保存的肾脏,129例接受了用欧洲柯林斯液保存的肾脏。两组供体和受体的人口统计学特征相同。中位(及范围)保存时间相似(欧洲柯林斯液组为24小时,UW液组为24小时)。每组的最长保存时间约为48小时。结果表明,UW液是一种安全的肾脏保存液,术后肾功能至少与接受用欧洲柯林斯液保存的肾脏进行移植的患者相当。在对257个肾脏的初步分析中,与用欧洲柯林斯液保存的肾脏相比,使用UW液可使术后血清肌酐下降更快、肌酐清除率更高,且术后透析更少(21%对31%)。本研究表明,UW液是临床肾脏移植的一种有效保存介质。它支持将UW液用作所有用于移植的腹腔内器官的通用冲洗和冷藏液。